Danaher Corporation vs Abbvie Inc.
DHR vs ABBV — side-by-side comparison from reported financials. DHR leads 4, ABBV leads 6 of 10 comparable metrics.
Danaher Corporation
DHR · Healthcare
$219.81+1.08%Mixed
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
| Metric | DHR | ABBV |
|---|---|---|
| Price | $219.81 | $276.43 |
| Market cap | $155B | $488B |
| Revenue (TTM) | $25.1B | $64.4B |
| Revenue growth | -2.7% | +1.8% |
| Net margin | 15.9% | 9.8% |
| Free cash flow | $5.47B | $18.2B |
| Net cash (debt) | ($13.8B) | ($56.2B) |
| 1-year price return | +7.5% | +19.8% |
| P/E | 38.6 | 77.4 |
| P/E vs own history (cheap-side %) | 38% | 23% |
| Dividend yield | 0.62% | 2.45% |
| Return on equity | 8% | 96% |
| Altman Z-score | — | 2.33 |
| CV checks passed | 9 of 11 | 9 of 11 |
| Employees | 60,000 | 57,000 |
Full résumé-style profiles: DHR CV · ABBV CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.